Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 2019, Article ID 5430493, 6 pages
https://doi.org/10.1155/2019/5430493
Research Article

Group B Streptococcus (GBS) Colonization and Disease among Pregnant Women: A Historical Cohort Study

1Maternal Fetal Medicine, WakeMed Health and Hospitals, Raleigh, NC, USA
2Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, USA
3The Emmes Corporation, Rockville, MD, USA
4Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA
5Department of Pediatrics, Duke University Medical Center, Durham, NC, USA

Correspondence should be addressed to James M. Edwards; gro.demekaw@sdrawdemaj and Geeta K. Swamy; ude.ekud@ymaws.ateeg

Received 25 September 2018; Revised 28 November 2018; Accepted 1 January 2019; Published 3 February 2019

Academic Editor: Bryan Larsen

Copyright © 2019 James M. Edwards et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Seale, F. Bianchi-Jassir, N. Russell et al., “Estimates of the burden of group b streptococcal disease worldwide for pregnant women, stillbirths and children,” Clinical Infectious Diseases, vol. 65, supplement 2, pp. S200–S219, 2017. View at Publisher · View at Google Scholar
  2. H. K. Ahmadzia and R. P. Heine, “Diagnosis and management of group B streptococcus in pregnancy,” Obstetrics and Gynecology Clinics of North America, vol. 41, no. 4, pp. 629–647, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. American College of Obstetricians and Gynecologists Committee on Obstetric Practice, “ACOG Committee Opinion no. 485: prevention of early-onset group B streptococcal disease in newborns,” Obstetrics & Gynecology, vol. 117, no. 4, pp. 1019–1027, 2011. View at Publisher · View at Google Scholar
  4. G. G. G. Donders, S. A. Halperin, and R. Devlieger, “Maternal Immunization With an Investigational Trivalent Group B Streptococcal Vaccine: A Randomized Controlled Trial,” Obstetrics & Gynaecology, vol. 127, no. 2, p. 213, 2016. View at Google Scholar
  5. S. A. Madhi, Z. Dangor, P. T. Heath et al., “Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants,” Vaccine, vol. 31, supplements 2, no. 4, pp. D52–D57, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Hall, N. H. Adams, L. Bartlett et al., “Maternal Disease with Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses,” Clinical Infectious Diseases, vol. 65, supplements 2, pp. S112–S124, 2017. View at Publisher · View at Google Scholar · View at Scopus
  7. H. L. Minkoff, M. F. Sierra, G. F. Pringle, and R. H. Schwarz, “Vaginal colonization with Group B beta-hemolytic streptococcus as a risk factor for post-cesarean section febrile morbidity,” American Journal of Obstetrics & Gynecology, vol. 142, no. 8, pp. 992–995, 1982. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Krohn, S. L. Hillier, and C. J. Baker, “Maternal peripartum complications associated with vaginal group B streptococci colonization,” The Journal of Infectious Diseases, vol. 179, no. 6, pp. 1410–1415, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. M. K. Yancey, P. Duff, P. Clark, T. Kurtzer, B. H. Frentzen, and P. Kubilis, “Peripartum infection associated with vaginal group B streptococcal colonization,” Obstetrics & Gynecology, vol. 84, no. 5, pp. 816–819, 1994. View at Google Scholar · View at Scopus
  10. A. E. Muller, P. M. Oostvogel, E. A. P. Steegers, and P. J. Dörr, “Morbidity related to maternal group B streptococcal infections,” Acta Obstetricia et Gynecologica Scandinavica, vol. 85, no. 9, pp. 1027–1037, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. A. T. N. Tita and W. W. Andrews, “Diagnosis and management of clinical chorioamnionitis,” Clinics in Perinatology, vol. 37, no. 2, pp. 339–354, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. D. J. Rouse, M. Landon, K. J. Leveno et al., “The maternal-fetal medicine units cesarean registry: Chorioamnionitis at term and its duration - Relationship to outcomes,” American Journal of Obstetrics & Gynecology, vol. 191, no. 1, pp. 211–216, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Cape, R. E. Tuomala, C. Taylor, and K. M. Puopolo, “Peripartum bacteremia in the era of group B streptococcus prophylaxis,” Obstetrics & Gynecology, vol. 121, no. 4, pp. 812–818, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Romero, M. Mazor, E. Oyarzun, M. Sirtori, Y. K. Wu, and J. C. Hobbins, “Is there an association between colonization with group B Streptococcus and prematurity?” The Journal of Reproductive Medicine, vol. 34, no. 10, pp. 797–801, 1989. View at Google Scholar
  15. J. M. Arias-Camison, “Late onset group B streptococcal infection from maternal expressed breast milk in a very low birth weight infant,” Journal of Perinatology, vol. 23, no. 8, pp. 691-692, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Le Doare and B. Kampmann, “Breast milk and Group B streptococcal infection: Vector of transmission or vehicle for protection?” Vaccine, vol. 32, no. 26, pp. 31280–33132, 2014. View at Google Scholar · View at Scopus
  17. E. von Elm, D. G. Altman, M. Egger, S. J. Pocock, P. C. Gøtzsche, and J. P. Vandenbroucke, “The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies,” Annals of Internal Medicine, vol. 147, no. 8, pp. 573–577, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. M. M. Horvath, S. A. Rusincovitch, S. Brinson, H. C. Shang, S. Evans, and J. M. Ferranti, “Modular design, application architecture, and usage of a self-service model for enterprise data delivery: The Duke Enterprise Data Unified Content Explorer (DEDUCE),” Journal of Biomedical Informatics, vol. 52, pp. 231–242, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. National Center for Immunization and Respiratory Disease DoBD, “Active Bacterial Core surveillance: Case Definition and Ascertainment,” 2016.
  20. G. Zou, “A modified poisson regression approach to prospective studies with binary data,” American Journal of Epidemiology, vol. 159, no. 7, pp. 702–706, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. J. M. Piper, S. Georgiou, E. M.-J. Xenakis, and O. Langer, “Group B streptococcus infection rate unchanged by gestational diabetes,” Obstetrics & Gynecology, vol. 93, no. 2, pp. 292–296, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. A. S. Bossick, R. M. Peters, C. Burmeister, N. Kakumanu, J. E. Shill, and A. E. Cassidy-Bushrow, “Antenatal inflammation and gestational diabetes mellitus risk among pregnant African-American women,” Journal of Reproductive Immunology, vol. 115, pp. 1–5, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. S. A. Abariga and B. W. Whitcomb, “Periodontitis and gestational diabetes mellitus: A systematic review and meta-analysis of observational studies,” BMC Pregnancy and Childbirth, vol. 16, no. 1, 2016. View at Google Scholar · View at Scopus
  24. W. A. Grobman, C. B. Parker, M. Willinger et al., “Racial Disparities in Adverse Pregnancy Outcomes and Psychosocial Stress,” Obstetrics & Gynecology, vol. 131, no. 2, pp. 328–335, 2018. View at Publisher · View at Google Scholar